Literature DB >> 33032880

COVID-19: Combined supply-side and demand-side shocks, so lift restrictions (carefully) lest GPD declines ultimately kill more than COVID-19.

Victor Grech1, Peter Grech2.   

Abstract

COVID-19 remains pandemic. Social distancing and travel restrictions have avoided countless deaths and infections but disrupted livelihoods and economies. The global loss of gross (world) product is unprecedented as COVID-19 has inflicted both a supply-side and a demand-side shock. While public health measures have mitigated morbidity and mortality, the excessive loss of GDP will lead to years of life lost due to recession with diminished spend on healthcare, safety and the environment. This paper will review the estimated COVID-19 economic impact and show that it is timely and crucial to (carefully) ease restrictions as any additional economic slide will continue to intensify an already parlous situation and further negatively impact overall global average human life expectancy. The USA and UK will be used as specific examples, as will the general case of delayed cancer treatment due to COVID-19 service disruption. Financial stimuli that attempt to revive flagging economies by governments and blocs will be outlined and the current uniformly bleak global forecasts will be briefly contrasted with the Great Depression of the 1930s. The biased adverse impact on low-income households will be sketched, and a reminder of the unknown eventual costs of lasting illness ("long COVID") will also have to be factored in restriction removal policies. At this point in time (end of summer 2020), fierce debates rage within each country regarding the potential trade-offs of health vs economy. The need for unbiased and rigorous quantitative evaluations of all possible decisions is paramount.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  COVID-19; Depression; Economics; Health economics; Recession

Year:  2020        PMID: 33032880      PMCID: PMC7528901          DOI: 10.1016/j.earlhumdev.2020.105209

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  17 in total

1.  Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.

Authors:  Seth Flaxman; Swapnil Mishra; Axel Gandy; H Juliette T Unwin; Thomas A Mellan; Helen Coupland; Charles Whittaker; Harrison Zhu; Tresnia Berah; Jeffrey W Eaton; Mélodie Monod; Azra C Ghani; Christl A Donnelly; Steven Riley; Michaela A C Vollmer; Neil M Ferguson; Lucy C Okell; Samir Bhatt
Journal:  Nature       Date:  2020-06-08       Impact factor: 49.962

2.  The effect of large-scale anti-contagion policies on the COVID-19 pandemic.

Authors:  Solomon Hsiang; Daniel Allen; Sébastien Annan-Phan; Kendon Bell; Ian Bolliger; Trinetta Chong; Hannah Druckenmiller; Luna Yue Huang; Andrew Hultgren; Emma Krasovich; Peiley Lau; Jaecheol Lee; Esther Rolf; Jeanette Tseng; Tiffany Wu
Journal:  Nature       Date:  2020-06-08       Impact factor: 49.962

3.  Planning for the Post-COVID Syndrome: How Payers Can Mitigate Long-Term Complications of the Pandemic.

Authors:  David H Jiang; Rozalina G McCoy
Journal:  J Gen Intern Med       Date:  2020-07-22       Impact factor: 5.128

4.  Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.

Authors:  Amit Sud; Bethany Torr; Michael E Jones; John Broggio; Stephen Scott; Chey Loveday; Alice Garrett; Firza Gronthoud; David L Nicol; Shaman Jhanji; Stephen A Boyce; Matthew Williams; Elio Riboli; David C Muller; Emma Kipps; James Larkin; Neal Navani; Charles Swanton; Georgios Lyratzopoulos; Ethna McFerran; Mark Lawler; Richard Houlston; Clare Turnbull
Journal:  Lancet Oncol       Date:  2020-07-20       Impact factor: 41.316

5.  Poverty, inequality and COVID-19: the forgotten vulnerable.

Authors:  J A Patel; F B H Nielsen; A A Badiani; S Assi; V A Unadkat; B Patel; R Ravindrane; H Wardle
Journal:  Public Health       Date:  2020-05-14       Impact factor: 2.427

6.  Persistent Symptoms in Patients After Acute COVID-19.

Authors:  Angelo Carfì; Roberto Bernabei; Francesco Landi
Journal:  JAMA       Date:  2020-08-11       Impact factor: 56.272

Review 7.  The socio-economic implications of the coronavirus pandemic (COVID-19): A review.

Authors:  Maria Nicola; Zaid Alsafi; Catrin Sohrabi; Ahmed Kerwan; Ahmed Al-Jabir; Christos Iosifidis; Maliha Agha; Riaz Agha
Journal:  Int J Surg       Date:  2020-04-17       Impact factor: 6.071

8.  Economic interventions to ameliorate the impact of COVID-19 on the economy and health: an international comparison.

Authors:  Shaun Danielli; Raman Patria; Patrice Donnelly; Hutan Ashrafian; Ara Darzi
Journal:  J Public Health (Oxf)       Date:  2021-04-12       Impact factor: 2.341

9.  The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.

Authors:  Camille Maringe; James Spicer; Melanie Morris; Arnie Purushotham; Ellen Nolte; Richard Sullivan; Bernard Rachet; Ajay Aggarwal
Journal:  Lancet Oncol       Date:  2020-07-20       Impact factor: 54.433

10.  "Stay at Home, Protect the National Health Service, Save Lives": A cost benefit analysis of the lockdown in the United Kingdom.

Authors:  David K Miles; Michael Stedman; Adrian H Heald
Journal:  Int J Clin Pract       Date:  2020-09-21       Impact factor: 3.149

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.